Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
This is a registry study in adult patients with newly diagnosed or refractory/relapsed acute myeloid leukemia.
Investigator's sites: 60 sites in Germany.
Primary objectives:
see brief summary
Inclusion Criteria:
Exclusion Criteria:
christoph.roellig@uniklinikum-dresden.de
Neubrandenburg, Mecklenburg-Vorpommern 17036, Germany
Bielefeld, North Rhine-Westphalia 33604, Germany
Siegen, North Rhine-Westphalia 57074, Germany